Shares of InMode Ltd INMD are trading lower Monday morning after the Israeli medical technology company said a special ...

Following a careful review of the final proposals received in connection with the potential transaction, the Committee has ...

InMode Ltd. is rated a Strong Buy due to its robust balance sheet, proprietary technology, and international growth. Learn more about INMD stock here.

InMode halts control sale after rejecting final bids including Centroid Sale process shelved as InMode board rejects all final bids, including from Centroid ...

Interested investors are welcome to contact their BTIG salesperson and schedule a meeting. For more information about the event, visit InMode's investor relations site here.

・Steel Partners has offered $18.00 per share to acquire a majority stake in InMode. ・The investment firm said the proposal would be fully funded from cash on hand and borrowing capacity under its ...

InMode (NASDAQ: INMD) is a medical device company that provides its consumers with a wide range of treatments to help with contouring skin, treating acne, removing hair, and other aesthetic issues.

InMode is a small-cap medical device company that invented a new way to do plastic surgery in a non-invasive way, via radio waves. The company is dominating its niche market, and the stock is up ...

It is hard to get excited after looking at InMode's (NASDAQ:INMD) recent performance, when its stock has declined 8.6% over the past three months. However, a closer look at its sound financials might ...

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable ...

In 2021, it seemed as if medical technology stocks could do no wrong. Shares of cosmetic sculpting device manufacturer InMode (NASDAQ: INMD) more than doubled as enthusiasm for all things new and ...